Commonwealth Retirement Investments LLC Sells 585 Shares of UnitedHealth Group Incorporated $UNH

Commonwealth Retirement Investments LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 5.4% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 10,272 shares of the healthcare conglomerate’s stock after selling 585 shares during the quarter. UnitedHealth Group makes up 1.2% of Commonwealth Retirement Investments LLC’s holdings, making the stock its 23rd largest position. Commonwealth Retirement Investments LLC’s holdings in UnitedHealth Group were worth $3,205,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the business. Supplemental Annuity Collective Trust of NJ raised its stake in UnitedHealth Group by 43.3% in the 2nd quarter. Supplemental Annuity Collective Trust of NJ now owns 4,300 shares of the healthcare conglomerate’s stock valued at $1,341,000 after acquiring an additional 1,300 shares during the period. NJ State Employees Deferred Compensation Plan raised its position in shares of UnitedHealth Group by 1,800.0% in the second quarter. NJ State Employees Deferred Compensation Plan now owns 9,500 shares of the healthcare conglomerate’s stock valued at $2,964,000 after purchasing an additional 9,000 shares during the period. Homestead Advisers Corp raised its holdings in UnitedHealth Group by 76.7% in the 2nd quarter. Homestead Advisers Corp now owns 192,300 shares of the healthcare conglomerate’s stock valued at $59,992,000 after acquiring an additional 83,500 shares during the period. Cassaday & Co Wealth Management LLC raised its holdings in UnitedHealth Group by 42.8% in the 2nd quarter. Cassaday & Co Wealth Management LLC now owns 8,769 shares of the healthcare conglomerate’s stock valued at $2,736,000 after acquiring an additional 2,627 shares during the period. Finally, RiverGlades Family Offices LLC increased its stake in shares of UnitedHealth Group by 12.5% during the second quarter. RiverGlades Family Offices LLC now owns 1,800 shares of the healthcare conglomerate’s stock worth $562,000 after purchasing an additional 200 shares during the period. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Baird R W lowered UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Truist Financial increased their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, September 9th. Mizuho raised their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research report on Thursday, October 9th. Sanford C. Bernstein raised their target price on shares of UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Finally, Piper Sandler lowered their target price on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating on the stock in a report on Tuesday, October 28th. Eighteen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $397.12.

UnitedHealth Group Price Performance

UNH stock opened at $330.56 on Wednesday. The company’s 50-day moving average price is $344.70 and its two-hundred day moving average price is $324.06. The firm has a market cap of $299.43 billion, a P/E ratio of 17.25, a P/E/G ratio of 2.28 and a beta of 0.47. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. During the same period last year, the firm posted $7.15 earnings per share. The firm’s quarterly revenue was up 12.2% compared to the same quarter last year. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.7%. UnitedHealth Group’s payout ratio is 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.